PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsintrahepatic cholestasis
MeSH D002780 - intrahepatic cholestasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D008107:Liver diseases
$
Success rate
D002779:Cholestasis
$
Success rate
D002780: 
Intrahepatic cholestasis
$
Success rate
D008105:Biliary liver cirrhosis
$
Success rate
D016738:Alagille syndrome
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Albireo PharmaOdevixibat Bylvay  2021-07-16   
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
83%
5/6
Phase 3
14%
1/7
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Albireo Pharma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use